2007
2 October 2007
The COMS2007 conference held in Melbourne in early September was the largest small technologies conference held in Australia, and was rated by organizers as the most successful COMS yet held. Over 600 delegates and visitors attended the three days, which were launched by the Honourable Evan Thornley MP, Parliamentary Secretary for the National Reform Agenda and Innovation. More…
1 October 2007
Nanotechnology Victoria (”NanoVic”) is pleased to announce that it will be hosting an “Artist in Residence” for the next 10 months. This continues the efforts over the last two years to explore opportunities at the interface between technology development and artistic expression. More…
28 August 2007
Interstitial NS announces the strengthening of its delivery portfolio with the filing of the nanoparticle vaccine provisional patent on the 20th August. More…
27 July 2007
Following the launch of The University of Melbourne’s Centre for Health and Society Needle and Syringe Cultures Exhibition on July 18, the national daily The Australian featured the exhibition in its Higher Education supplement of July 25th More…
2 April 2007
Nanotechnology Victoria’s Delivery & Sensing team of Dr Jeanette Pritchard, Dr Michelle Critchley, and Dr Bob Irving has contributed a Special Report to the latest issue of Nanomedicine. The Report, Nanotechnology: the Next Wave of Commercial Development for Health and Medical Devices - The Australian Story appears in Nanomedicine 2(2) in April 2007. More…
8 March 2007
The Interstitial NS Transdermal Platform was cited in a group of Prime Technology Innovations at an Analyst Briefing Teleconference in early February. The Briefing was conducted by Frost & Sullivan from their Singapore office. Frost & Sullivan are one of the leading analysts of nanotechnology and biotechnology trends, and regularly provide Technical insights briefings. More…
|
